Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report

Muhannad A Alsemari,Hakeam A Hakeam,Hussain Alsalman,Tarek Amin
DOI: https://doi.org/10.1177/2049936120952605
2020-08-26
Abstract:High-dose tigecycline therapy is gaining wide acceptance in treating infections caused by multidrug-resistant bacteria. There are no reports of cutaneous hyperpigmentation with the use of high-dose tigecycline. Here we report a case of a woman who developed reversible cutaneous hyperpigmentation within 48 h of receiving high-dose tigecycline.
What problem does this paper attempt to address?